Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: Long-term follow-up of a prospective, randomised, multicentre trial

Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz, Stephen E. Sallan, Lewis B. Silverman, Tracie L. Miller, Elly V. Barry, Barbara L. Asselin, Uma Athale, Luis A. Clavell, Eric Larsen, Albert Moghrabi, Yvan Samson, Bruno Michon, Marshall A. Schorin, Harvey J. Cohen, Donna S. Neuberg, E. John Orav, Steven D. Colan

Research output: Contribution to journalArticlepeer-review

271 Scopus citations

Fingerprint Dive into the research topics of 'Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: Long-term follow-up of a prospective, randomised, multicentre trial'. Together they form a unique fingerprint.

Medicine & Life Sciences